Master Course in Heart Failure 2026 - Nairobi
-
City
Nairobi, Kenya
Type of event
on site
Save the Date!
Master Course in Heart Failure Nairobi
Nairobi, Kenya, 23.-26.09.2026
Venue: Radisson Blu Hotel, Upperhill
Directors: Prof. Thomas Lüscher, Prof. Elijah Ogola, Dr. Kieran Mwazo, Dr. Anders Barasa, Dr. Leonard Ngunga
Scientific Coordinator: Christine Lohmann, Zurich / Lilian Muga, KCS, Nairobi
Registration details to follow soon!
Tentative Programme
DAY 1 • Wednesday, 23rd September, 2026
| FACULTY NETWORKING SESSION Heart Failure in East Africa: A Different Epidemic | ||
| 11:30 | Arrival and Faculty Registration | |
| 12:00 | Introductions | Course Directors, Nairobi |
| 10:20 | Cardiovascular disease – the new epidemic in Bulgaria | |
| 12:30 | Faculty Only Networking lunch | |
| OPENING SESSION: Heart Failure in East Africa: A Different Epidemic | T.F. Lüscher, A. Barasa, L. Ngunga | |
| 14:00 | Arrival and Delegate Registration | |
| 14:30 | Welcome and learning objectives | Course Directors, Nairobi |
| 14:45 | OPENING LECTURE The Spectrum of Heart Failure: What it Means for Practice | Thomas F. Lüscher |
| 15:05 | Local HF data: Kenya Heart Registry, THESUS-HF and INTER-CHF: What the data tell us | Elijah Ogola |
| 15:20 | Unique drivers of HF in SSA: hypertension, RHD, PPCM, HIV-CM | Kieran Mwazo |
| 15:35 | Use of Biomarkers in HF (African Experience) | Benard Gitura |
| 15:50 | Panel Discussion | All faculty |
| 16:00 | COFFEE BREAK | ||
| SESSION 1 Master Class: How to Assess the Heart Failure Patient Chairs: Anders Barasa, Benard Gitura, Yubrine Moraa | ||
| 16:20 | MAGISTRAL LECTURE Clinical Assessment of HF: History and Examination (Latest ESC Guidelines) | Theresa A. McDonagh |
| 16:40 | Clinical Case: A Kenyan patient presenting with breathlessness: step-by-step assessment (The Lung or the Heart) | Blanche Cupido |
| 16:50 | Who is Congested? Bedside Assessment, Lung Ultrasound and Biomarkers and congestion scores | Hatem Soliman Aboumarie |
| 17:00 | When is the Patient Truly Decongested? Targets and Pitfalls | Anders Barasa |
| 17:20 | Multimodality Imaging for HF Assessment: Echo, CMR and Nuclear – What to Order When | Ronny Büchel |
| 17:30 | Panel discussion | All faculty |
| 18:00 | Welcome Reception and KCS Heart Failure Working Group Networking Dinner | ||
DAY 2 • Thursday, 24th September, 2026
| SESSION 2 Hypertensive Heart Disease and HFpEF: An Emerging Kenyan Phenotype Chairs: Elijah Ogola, James Kayima | ||
| 08:30 | Clinical Case: Hypertensive HFpEF in a 58-year-old Nairobi woman: diagnosis and management | Hazel Mburu |
| 08:50 | Diagnosing HFpEF in 2026: Beyond the algorithms (HFA-PEFF &H2FPEF – What's New? | Marco Metra |
| 09:10 | Treating Hypertension and HFpEF 2026: SGLT2i, GLP-1 RA, MRA – Latest Evidence and Practical Use according to the ESC guidelines | Sofie Brouwers online |
| 09:30 | Comprehensive Imaging in Heart Failure (HFpEF) | Yubrine Moraa |
| 09:50 | Panel discussion | All faculty |
| 10:00 | COFFEE BREAK | ||
| SESSION 3 State-of-the-Art Assessment of Ischaemic Cardiomyopathy Chairs: Anders Barasa, Mzee Ngunga, Keith Dindi | ||
| 10:30 | Clinical Case: Cardiomyopathy in a late-presenting Kenyan patient: to revascularize or not? | Kieran Mwazo |
| 10:50 | PCI vs CABG in Ischaemic HF: How to Choose in the Kenyan Setting (Cardiothoracic Surgeon & Interventional cardiologist perspective) | Jeilan Mohamed/Arega Fekadu |
| 11:20 | Ischaemic CM: Diagnosis, Viability, Imaging and Risk Stratification | Ronny Büchel |
| 11:40 | Putting it all together | Anders Barasa or Mzee Ngunga |
| 12:00 | Panel discussion | All Faculty |
| 12:30 | LUNCH BREAK | ||
| SESSION 4 Master Class: Guideline-Based Medical Therapy – Titration in Practice Chairs: Anders Barasa, David Silverstein, Eleanor Wicks | ||
| 13:30 | MAGISTRAL LECTURE The Fantastic Four: Starting, Sequencing and Up-Titrating GBMT in HFrEF | Thomas F. Lüscher |
| 13:50 | Clinical Case: Up-titration workshop: Three Kenyan patients, three different problems | Duncan Kilingo |
| 14:10 | Sacubitril/Valsartan: Who Gets It, How Fast, and what to Do with Renal Impairment | Anders Barasa |
| 14:30 | SGLT2 Inhibitors Across the LVEF Spectrum: From HFrEF to HFpEF | Theresa A. McDonagh |
| 14:50 | Finerenone and Non-Steroidal MRA: New Options in heart failure | John McMurray online |
| 15:10 | Medical Inertia and Polypharmacy: Closing the Evidence-to-Practice Gap in Kenya | Hasham Varwani |
| 15:20 | Digitalis in Heart Failure – Outdated or a must – Recent publications | Benard Gitura |
| 15:30 | COFFEE BREAK | ||
| SESSION 5 Master Class: Right and Left Heart Catheterisation – Practical Haemodynamics in Kenyan HF Chairs: Mayooran Shanmuganathan, Charles Kariuki, Mohamed Jeilan | ||
| 15:50 | MAGISTRAL LECTURE Why Haemodynamic Phenotyping Still Matters: From Wedge to Waveform | Stephan Rosenkranz |
| 16:10 | Clinical Case: Interpreting RHC tracings: two challenging Kenyan HF scenarios | Mzee Ngunga/Kieran Mwazo |
| 16:30 | RHC Technique, Waveform Interpretation and Common Pitfalls | Mayooran Shanmuganathan |
| 16:50 | Group 2 Pulmonary Hypertension: Diagnosis, Clinical Implications and Vasodilator Testing | Stephan Rosenkranz |
| 17:10 | RHC-Guided Management: Fluid Status, Inotrope Weaning and Transplant Evaluation | Mayooran Shanmuganat |
| 17:30 | Left Heart Catheterization in Heart Failure | Stephan Rosenkranz |
| 17:50 | Panel Discussion | All Faculty |
| 18:00 | End of Day 2 | |
DAY 3 • Friday, 25th September, 2026
| SESSION 6 Not Everything is Ischaemic: Differential Diagnosis and Specific Cardiomyopathies Chairs: Benard Gitura, Felix Barasa | ||
| 09:00 | Clinical Case: Restrictive physiology in a (Kenyan) patient: amyloid, EMF or constrictive pericarditis? | Sarah Krauss |
| 08:50 | Classification of Cardiomyopathies: ESC 2023 Framework in Practice | Eleanor Wicks |
| 09:10 | Peripartum Cardiomyopathy in East Africa: Incidence, Bromocriptine and Outcomes | Blanche Cupido |
| 09:20 | HIV-Associated Cardiomyopathy and Cardiac Complications of ART | Felix Barasa |
| 09:40 | ATTR Cardiac Amyloidosis: The Underdiagnosed Elephant – Diagnosis and Treatment in 2025 | Sarah Kraus |
| 10:00 | Panel discussion | All Faculty |
| 10:30 | COFFEE BREAK | ||
| SESSION 7 Valvular Heart Disease in Kenya: Rheumatic and Beyond Chairs: Arega Leta, James Kayima | ||
| 10:50 | Clinical Case: Pregnant patient with severe mitral stenosis and acute pulmonary oedema | Constantine Akwanalo |
| 11:10 | RHD in Kenya: Burden and the Prevention Roadmap | Felix Barasa |
| 11:30 | Mitral Stenosis and Regurgitation: PMBV vs Surgery - Patient Selection and Outcomes | Chris Jowi |
| 11:50 | Aortic Valve Disease in HF: TAVR Evidence and Realistic Access Pathways in Africa | Etienne Amendezo |
| 12:10 | Tricuspid Regurgitation and Secondary Valvular Disease in HF | Sanjeev Bhattacharyya online |
| 12:30 | Double Valve Disease | Liesl Zühlke, online |
| 12:30 | Panel Discussion | All Faculty |
| 13:00 | LUNCH BREAK Group Photograph | ||
| SESSION 8 Masterclass: Cardio-Oncology & Heart Failure: Chairs: Kieran Mwazo, Anne Mwirigi | ||
| 14:00 | MAGISTRAL LECTURE Cancer in Heart Failure: Assessment, management and follow-up | Charlotte Manisty |
| 14:30 | Clinical Case: Baseline Risk Assessment | Kieran Mwazo |
| 14:50 | Cardiovascular Disease in patients with Cancer – Beyond LV Dysfunction | Charlotte Manisty |
| 15:10 | Rapid Fire Cases in Cardio-Oncology | ShaneAli/Abdurahman Abud/Anne Mwirigi/Joseph Abuodha |
| 15:40 | State of Cardio-Oncology in East Africa | Kieran Mwazo |
| 15:50 | Panel Discussion | All Faculty |
| 16:30 | COFFEE BREAK | ||
| SESSION 9 Obesity – The Upstream Monster Driving Heart Failure Numbers Chairs: Eric Njenga, David Silverstein | ||
| 17:00 | Clinical Case: Obese patient with HFpEF, T2DM and AF: building the treatment plan | Yubrine Moraa |
| 17:20 | The Obesity Epidemic in Kenya and East Africa: Epidemiology and Projections | Eric Njenga |
| 17:40 | GLP-1 Receptor Agonists in HFpEF: STEP-HFpEF, FLOW and SELECT – What the Trials Show | Blanche Cupido |
| 18:00 | SGLT2 Inhibitors and Cardiometabolic Therapy: Practical Prescribing in the Kenyan Context | Yubrine Moraa |
| 18:20 | Panel Discussion | All FAculty |
| 19:00 | Conference Dinner | ||
DAY 4 • Saturday, 26th September, 2026
| SESSION 10 Acute and Worsening Heart Failure: Decongestion & the Hospital-to-Home Transition Chairs: Swaleh Misfar, Mzee Ngunga | ||
| 08:30 | MAGISTRAL LECTURE Acute Heart Failure 2026 – What Has Changed? The 2026 ESC Guidelines | Marco Metra |
| 08:50 | Clinical Case: Acute decompensation in a patient on optimal GDMT: what do we do next? | Misfar Swaleh |
| 09:10 | Haemodynamic Profiles in ADHF: Warm, cold, dry, wet The Nohria-Stevenson Matrix in Practice | Hatem Soliman Aboumarie |
| 09:30 | Decongestion Strategies: PUSH, CARRESS-HF, ADVOR and Acetazolamide | Wilfred Mullens |
| 09:50 | Worsening HF: From Hospital to Home – STRONG-HF and Early Intensive Up-Titration | Alexander Mebazaa online |
| 10:10 | Building HF Clinics in Kenya: Nurse-Led Models, Task-Shifting and Digital Tools | Anders Barasa |
| 10:25 | Rapid Fire Cases Management in the Emergency Room | Eleanor Wicks |
| 10:40 | Panel discussion | All Faculty |
| 10:50 | COFFEE BREAK | ||
| SESSION 11 Advanced Heart Failure: Patient Selection, MCS and Getting There in Kenya Chairs: Mohamed Jeilan, Charles Kariuki | ||
| 11:20 | MAGISTRAL LECTURE Advanced Heart Failure: Past, Present and the Future | Marco Metra |
| 11:40 | Clinical Case: Advanced HF pathway: a Kenyan patient's journey from ward to referral | Mzee Ngunga |
| 12:00 | Defining Advanced HF: INTERMACS Profiles, Recognition and Timely Referral | Mayooran Shanmuganathan |
| 12:20 | Cardiogenic Shock: Risk Stratification, Inotropes and Escalation Thresholds | Hatem Soliman Aboumarie |
| 12:40 | Impella and Short-Term MCS: Evidence, Technique and Patient Selection | Christian Hassager online |
| 13:00 | LVAD as Destination Therapy vs Bridge to Transplant: MOMENTUM-3 and ENDURANCE | Mayooran Shanmuganathan |
| 13:20 | Heart Transplantation in Africa: The SA Experience and the Kenyan Roadmap | Keith Dindi |
| 13:40 | The flipside of the coin - The patients experience | Laurence Humpreys Davies |
| 13:55 | Panel Discussion | All Faculty |
| 14:00 | LUNCH BREAK | ||
CLOSING KCS Heart Failure Working Group: Roadmap to 2030 and Call to Action | ||
| 15:00 | Key Learning Points and Clinical Take - Aways from the Three Days | Course Directors |
| 15:20 | KCS HF Working Group Workstreams: HF Protocols, Registry, Community Burden, Imaging, Advanced Therapies KCS HF Working Group | |
| 15:40 | Certificate Ceremony, Closing Remarks and Group Photograph | |
The programme may be subject to change.
Under the auspices of
